Note. This is updated from a previous blog post I published a long time ago in robotic healthcare on November 29,2018 >>> Hello, World! You may remember from the pre-COVID times the use of the new genome editing technique CRISPR-Cas9 by He Jiankui, scientist at the Southern University of Science and Technology of China, to…
AI is forecasted to increase the region’s GDP greater than 5% by 2030. The report titled “Seizing the opportunity the future of AI in latin America” has a special focus on Argentina, Brazil, Chile, Colombia, and Mexico.
The authors suggest that vitamin D can likely reduce severe late stages of COVID-19 infection (as more studies are needed to verify this), while certainly benefiting bone and muscle health. One reason for its possible positive effects is the role of vitamin D in regulating and suppressing the inflammatory cytokine “storm” that leads to severe respiratory problems in patients with COVID-19.
A systematic study based on the review of 89 articles related to coronaviruses and drugs taken by patients suffering from previous diseases showed that there is no evidence for or against the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen to treat patients. with COVID-19. However, he noted that other types of drugs, such as TNF blockers and JAK inhibitors, are safe to use, and IL-6 could be beneficial in treating COVID-19.
